SPY362.06-1.61 -0.44%
DIA296.62-2.62 -0.88%
IXIC12,198.74-7.11 -0.06%

Catabasis Pharmaceuticals Q3 EPS $(0.56), Same YoY

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.56) per share. This is unchanged from the same period last year.

· 11/12/2020 16:13
Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.56) per share. This is unchanged from the same period last year.